SINDROME METABOLICA
CARATTERISTICHE

LIPOBES
60 capsule da 540 mg

–
Lipobes è un integratore alimentare a base di Riso Rosso fermentato, Omega 3 e Coenzima Q10. Contribuisce al benessere cardiovascolare e al mantenimento dei normali livelli di colesterolo e trigliceridi nel sangue.


APPROFONDIMENTI

SCHEDA INGREDIENTI
BIBLIOGRAFIA SCIENTIFICA

BIBLIOGRAFIA LIPOBES

  • A. Constantine, J.J. Maguire and L, Packer, Interactions between ubiquìnones and vitamins in membranes and cells, Molecuiar Aspects of Medicine 15(Suppl.) (1994), s57-s65.

  • A. Lawen, R.D. Martinius, G. McMullen, R Nagley, F. Vaillant, E.J. Wolvctang and A.W. Linnane, The universality of biocncrgctic discase; The role of mìtochondrial mutation and the putative inter-relationship between mitochondria and plasma membrane NADH oxidoreductase, Molecuìar Aspects of Medicine 1S (1994), sl3-s27.

  • A. Palomaki, K. Malminiemi and T MetsS-Ketela, Enhanced oxidizability of ubiquinol and alpha-tocophcrol during lovastatin treatment, FEBSLetter 410(2,3) (1997), 254-258.

  • A.M, Bargossi, M. Battine, A. Gaddi, P.L. Fiorella, G. Grossi, G. Barozzi, R, Di Giulio, G. Descovich, S. Sassi and M.L. Genova, Exogenous CoQio preserves plasma ubiquinone levels in patients treated with 3-hydroxy-3-methylglutaryI coenzyme A reductase inhibitors, Int. J. Ciin. Lab. Res. 24(3) (1994), 171-176.

  • A.M. Soja and S.A. Mortensen, Treatment of congestive heart failure with coenzyme Q10 ìlluminated by meta-analyses of clinical trials, Molecuìar Aspects of Medicine 18(Suppl.) (1997), S159-S168.
  • A.W. Linnane, C. Zhang, A. Baumer and P. Nagley, Mitochondrial DNA mutation and the aging process: bioenergy and pharmacological intervention, Mutation Research 275(1992), 195-208.
  • B, Permanetter, W, Rossy, G. Klein, F. Weingartner, K,F. Seidl and H. Blomer, Ubiquinone (coenzyme Qm) in the long-term treatment of idiopathic dilatedcardìomyopathy, European Heart J. 13(11) (1992), 1528-1533.
  • E, Rossi, A. Lombardo, M. Testa, S. Lippa, A, Oradei, G.P. Littarru, U.Manzoli et al., Coenzyme Q10 in ischaemic cardiopathy, in: Biomedica! and Clinical Aspects of Coenzyme Q, K.. Folkers, T. Yamagami and G.P. Littarru, eds, Vol. 6, Elsevier, Amsterdam, 1991, pp. 321-326.

  • E. Baggio, R. Gandini, A.C. Plancher. M. Passeri and G. Carmosino, Italian multìcenter study on the safety and efficacy of coenzyme Qio as adjunctive therapy in heart failure. CoQm Drug Surveillance Investigators, Molecuiar Aspecis of Medicine 15(Suppl.) (1994), s287 s294.

  • F. Rengo, P. Abete, P. Landino, D. Leosco, F. Covelluzzì, D, Vitale, N, Ferrara et al., Rolc of mctabolic therapy in cardiovascular discase, K. Folkers, S.A. Mortensen, G,P. Littarru, T. Yamagami and G. Lenaz, guest eds, The Clinical Investigai 1\ (1993), S124-S128.
  • F. Schardt, D. Welzel, W, Schiess and K. Toda, Effect of coenzyme Q10 on ischaemia-induced ST-segment deprcssion: a doublé blind, placebo-controlied crossover study, in: Biomedicai and Clinica! Aspects of Coenzyme Q, K. Folkers, T. Yamagami and G.P. Littarru, eds, Voi. 6, Elsevier, Amsterdam, 1986, pp. 385-403.

  • F.L. Crane and DJ. Morrè, Evidenee for coenzyme Q function in Golgi membranes, in: Biomedicai and Clinica! Aspects of Coenzyme Q, K. Folkers and Y Yamamura, eds, Elsevier, Amsterdam, 1977, pp. 3-14.

  • F.L. Crane, I.L. Sun, R. BarrandD.J. Morrò, Coenzyme Q in Golgi apparatus membrane redox acti vi ty and proton uptake, in; Biomedicai and Clinica! Aspects of Coenzyme Q, K. Folkers and Y. Yamamura, eds, Voi. 4, Elsevier, Amsterdam, 1984, pp. 77-86.

  • F.L. Grane, Y. Hatefi, R.I. Lester andC. Widmer. Isolation of aquinone from beef heart mitochondria, Biockim. Biophys. Ada 25(1957), 2201.

  • G. Lenaz and G. Parenti Castelli, Biologica) Membranes, G. Benga, ed., Voi. 1, CRC Press, Boca Raton, USA, 1984, pp. 93-136. [43] G. Lenaz and D. Esposti, Physìcal properties of ubiquìnones in model systems and membranes, in: Coenzyme Q. Bìo-chemistry, Bioenergetics and Clinica! Applications ofUbiquinone, G. Lenaz, ed., John Wiley & Sons, 1985, Chapter IV, pp. 83-105.
  • G. Lenaz, R. Fato, C. Castelluccio, M. Battino, M. Cavazzonì, H. Rauchova and G.P. Castelli, Coenzyme Q saturation kmeticsofmitochondrial enzymes: theory, experimental aspects and biomedicai implications, in: Biomedicaì and Clinica! Aspects of Coenzyme Q, K. Folkers, T Yamagami and G.P. Littarru, eds, Voi. 6, Elsevier, Amsterdam, 1991, pp. 11-18.
  • G. Lenaz, The role of mobility of redox components in the inner mitochondnal membrane, 3. Membr. Bioì. 104 (1988), 193-209.
  • G. Serra, F. Lissoni, C. Piemonti and C. Mazzola, Evaluation of CoQ10 in patients with moderate heart failure and chronic stab le effort angina, in: Biomedicai and Clinical Aspects ofCoenzyme g, K. Folkers, T Yamagami and G.P. Littarru, eds, VoL. 6, Elsevier, Amsterdam, 1991, pp. 327-338.
  • G.P. Littarru, L. Ho and K. Folkers. Deficiency of coenzyme Qm in human heart disease, Part I and II, Internai. J. Fu. Nutr. Res. 42(2) (1972), 291 ; 42(3), 413.
  • H. Rudney, A.M.D. Nambudiri and S. Ranganathan. The regulation of the synthesis of coenzyme Q in fibroblasts and in heart muscle, in: Biomedicai and Clinica! Aspects of Coenzyme Q, K. Folkers and Y Yamamura, eds, Vol. 3, Elsevier, North-Holland Press, 1981, pp. 279-290.
  • H. Yokoyama, D.M. Lingle, JA. Crestanello, J. Kamelgard, B.R, Kott, R, Momeni, J. Millili, S.A. Mortensen and G.J. Whitman, Coenzyme Qio proteets coronary endothelial function from ischemia reperfusion injury via an anti-oxidant effect, Surgery 120(2) (1996), 189-196.

  • H.A. Langsjoen, P.H. Langsjoen, P.H. Langsjoen, R. Willis and K.. Folkers, Usefulness of coenzyme Q10 in clinical cardiology: a long-term study, Molecuìar Aspects of Medicine 15(Suppl.) (1994), sl65-sl75.

  • IRH.VanFraechem, C, Picalausa and K.. Folkers, Effects of CoQio on physical performance and recovery in myocar- dial failurc, in: Biomedicai and Clinica! Aspects of Coenzyme Q, K. Folkers and Y, Yamamura, cds, VoL. 5, Elsevier, Amsterdam, 1986, pp. 371-377.

  • J. Tanaka, R. Tominaga, M. Yoshitoshi, K, Matsui, M. Komori, A. Sese, H, Yasui and K. Tokunaga, Coenzyme Qm: the prophylactic effect on low cardiac output following cardiac valve replacement. Annals ofThoracic Surgery 33(2) (1982),145-151.

  • J.M.Villalba, F. Navarro, C. Gomez-Diaz, A. Arroyo, R.I. Bello and P. Navas, Role of cytochrome bs reductase on theantioxidant function of coenzyme Q in the plasma membrane, G.P. Littarru, M. Alleva, M. Battine and K. Folkers, guest eds, Molecular Aspects of Medicine 18(Suppl.) (1997), s7–sl3.

  • K. Swedberg, C. Hoffman-Bang, N. Rehnqvist and H. Astrom, Coenzyme Q10 as an adjunctivc in treatment of congestive heart failure, J, Cardiac Failure 1(1995), 101 107. D.R Taggart, M. Jenkins, J. Hooper, L. Hadjinikolas, M. Kemp, D. Hue and G. Bennett, Effccts of short-term supplementation with coenzyme Qiu on myocardial protection during cardiac operatìons, Annals ofThoracic Surgery 61(3) (1996),
  • L. Poggesi, G. Galanti, M, Comeglio, L, Toncelli and M. Vinci, Effect of coenzyme Qio on left ventricular function in pa­tients with dilative cardiomyopathy. A medìum-term randomized double-blind study versus placebo, Current Therapeutic Research 49(5) (199Ì).

  • M,F, Wilson. W.H. Frishman.T. Giles, G. Sethi, S. Greenberg and J. Brackett, CoenzymeQm therapy and exercise duration in stablc angina, in: Biomedicai and Clinìcal Aspects of Coenzyme Q, K. Folkers, G.P. Littarru and T. Yamagami, eds, VoL. 6, Elsevier, Amsterdam, 1991, pp. 339-348.

  • M. Chello, P. Mastroroberto, R, Romano, E, Bevacqua, D. Pantaleo, R. Ascione. A.R. Marchese and N. Spampinato,

  • M. Chello, R Mastroroberto, R. Romano, P. Castaldo, E. Bevacqua and A.R, Marchese, Protection by coenzyme Q10 of tissue reperfusìon injury during abdominal aortic cross-clamping, J. Cardiovasc. Surg. (Torino) 37(3) (1996), 229-235.

  • M. Sunamori, H. Tanaka, T. Maruyama, I. Sultan, T. Sakamoto and A. Suzuki, Clinical experience of coenzyme Q10 to enhance intraopcrativc myocardial protectìon in coronary artery rcvascularization, Cardiovasc. Drugs Ther. 2(Suppl.) (1991), 297 300.
  • P, Richardson, J. Drzcwoski, J. Ellis, S. Shizukuishi, K. Takemura, L. Baker and K. Folkers, Reduction of elevatcd blood pressure by coenzyme Qm, in: Biomedicai and Clinical Aspects of Coenzyme Q, Voi. 3, Elsevier, Amsterdam, 1981, pp. 229-234.

  • P.H. Langsjoen, A. Langsjoen, R, Willis and K. Folkers, Treatment of hypertrophic cardiomyopathy with coenzyme Q10, Molecuìar Aspects of Medicine 18(Suppl.) (1997), sl45-sl51.

  • P.H. Langsjoen, P.H. Langsjoen and K. Folkers, Isolateti diastolic dysfunctìon of the myocardium and its response to CoQiu treatment, K. Folkers, S.A. Mortensen, G.P, Littarru, T. Yamagami and G. Lenaz, eds, Clinical Invcstigator 71 (1993), S140-S144.

  • P.H. Langsjoen. P.H. Langsjoen, R, Willis and K, Folkers, Treatment of essential hypertension wìth coenzyme Q10, The Molecuìar Aspects of Medicine 15(Suppl.) (1994), s265-s272.

  • Protection by coenzyme Q10 from myocardial reperfiision injury during coronary artery bypass grafting, Ann. Thorac. Surg. 58(5) (1994), 1427-1432.

  • R. Aejmelaeus, T. Metsa-Ketelà, P. Laippala, H. Alho and T. Solakvi, Ubiquinol-10 and total peroxyl radicai trapping capacity of LDL lipoproteins during aging: the effects of Q-10 supplementation, Molecuiar Aspecis of Medicine 18(Suppl.) (1997), sll3-s]20.

  • R. Alleva, M. Tomasctti, S. Bompadre and G.P. Littarru, Oxidation of LDL and their subfractions: kìnetic aspects and CoQ10 « coment, Molecuiar Aspecis of Medicine 18 (Suppl.) (1997), sl05-sL 12.

  • R.A. Willis, K.. Folkers, J.L. Tucker, C.Q. Ye, L,J. Xia and H. Tamagawa, Lovastatin decreases coenzyme Q levels in rats, Proceedlngs ofihe National Academy of Sciences USA 87(22) (1990), 8928-8930.

  • R.D. Martinius, A.W. Linnane and P. Nagley, Growth of human namalwa cells lacking oxidativc phosphorylatìon can be sustained by redox compounds potassium ferricyanide or coenzyme Qui putatively acting through the plasma membrane oxìdase, Bìocbem. Mol. Bioì. Internai. 31 (1993), 997-1005. [49] P. Mitchell, Possible molecuìar mechanismof the protonmotive function of cytochrome systems, J. Theor. Bioi. 62(1976), 327-367.

  • R.F. Beyer andL. Emster, The antioxidant roleof coenzyme Q, in: Highlights in Ubiquinone Research, G. Lenaz, O. Barnabei, A. Rabbi and M. Ballino, eds, Taylor and Francis, London, 1990, pp. 191-213.

  • RH. Langsjoen, A. Langsjoen. R. Willis and K. Folkers, The aging heart: rcvcrsal of diastolic dysfunction through the use of orai CoQm in the elderly, in: Anti-Aging Medicai Therapeutics, KM. Klatz and R. Goldman, eds, Health Quest Publications, 1997, pp. 113-120.

  • RL. Montaldo, G. Fadda, S. Salis, G. Satta, M. Tronci, R. DiCesare, R. Reina and A. Concu, Effects of the prolonged adm ini strati on of coenzyme Qio in borderline hypertensive patients: a hemodynamic study, in: Biomedical and Clinical Aspects of Coenzyme Q, VoL. 6, Elsevier, Amsterdam, 1991, pp. 417-424.
  • S.R. Thomas, J. Neuzil and R. Stocker, Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistancc of LDL to transition metal-dependent oxidation initìation, Arterioscler. Thromb. Vose. Biol. 16(5) (1996), 687-696.
  • S.R.Thomas, J. Neuzil and R. Stocker, Inhibition of LDL oxidation by ubiquinol-10. A protec live mechanism for coen­zyme Q in atherogenesis?, Molecuìar Aspects of Medicine 18(Suppl.) (1997), s85-sl03.

  • T. Nakamura, H. Sanma, M, Himeno and K. Kato, Transfer ofexogenous coenzyme Q1o to the inner membrane of heart mitochondria in rats, in: Biomedicai and Clinica! Aspects of Coenzyme Q, K. Folkers and Y. Yamamura, eds. Vol. 2, Elsevier, North-Holland Press, 1981, pp. 3-14.

  • T. Oda, Effect of coenzyme Q10 on load-induced cardiac dysfunction: doublé blind study and investìgation of dose-response relationship, in: Highlighrs in Ubiquinone Research, G. Lenaz, O. Barnabei, A. Rabbi and M. Ballino, eds, Taylor and Francis, London, 1990, pp. 232-237.

  • T. Oda, Recovery of the Frank-Starling mechanism by coenzyme Qiti in patients with load-induced contractility depression, Molecuìar Aspects of Medicine 15(Suppl) (1994), 149-154, T. Ozawa, Formation of oxygen radicals in the electron transfer chain and antioxidant properties of coenzyme Q, in: Coenzyme Q. Biochemistry, Bioenergetics and Clinica! Applications of Ubiquinone, G. Lenaz, ed.. John Wiley & Sons, 1985, Chapter XXI, pp. 441-456.

  • T. Tsuyuasaki, C. Noto and R. Kìkawada, Mechanocardiography of ischemie or hypertensive heart discasc, in; Biomedicai and Clinical Aspects of Coenzyme Q, Y.

  • T. Yamagami, M, Takagì, H. Akagami, H. Kubo, S. Toyama, T. Okamoto, T. Kishi and K. Folkers, Effect of coenzyme Qm on essential hypertension, a doublé blind controlied study, in: Bìomedicai and Clinical Aspects of Coenzyme Q, VoL, 5, Elsevier, Amsterdam, 1986, pp. 337-343.

  • T. Yamagami, N. Shibata and K. Folkers, Study of Coenzyme Qm in essential hypertension, in: Biomedicai and Clinical Aspects of coenzyme Q, K. Folkers and Y Yamamura, eds, Elsevier, Amsterdam, 1977, pp. 231-242.

  • W. Schneeberger, J. Mullcr-Stcinwachs, L.P. Anda, W. Fuchs, F. Zilliken, K. Lyson, K. Folkers et al., A clinical doublé blind and crossover trial with coenzyme Qm on patients with cardiac disease, in: Biomedicai and Clinical Aspects of Coenzyme Q, K. Folkers and Y. Yamamura, eds, VoL. 5, Elsevier, Amsterdam, 1986, pp. 325-333.

  • Y Yamamura, Jpn. Circ. J. 31 (1967), 168.

  • Y Yamamura, T. Ishiyama, Y Monta and T. Yamagami. Sago Rinsho 16 (1967), 1564-1572 (in Japanese).
  • Y Yamamura, T. Ishiyama, V. Monta, N. Tsukamoto. J. Kobayashi and T. Yamagami, Sogo Rinsho (Clinic Ali-round) 17 ( 1968), 1057-1065 {in Japanese).
  • Y. Yamamura, A surveyof the therapeutic usesof coenzyme Q, in: Coenzyme Q. Biochemistry, Bioenergetics and Clinica! Applications ofUbiquinone, G, Lenaz, ed., John Wiley & Sons, 1985, pp, 479-505.
  • Y. Yamamura, Clinical status of coenzyme Q and prospeets, in: Biomedicai and Clinical Aspects of Coenzyme Q,YL. Folk­ers and Y. Yamamura, eds, Elsevier, Amsterdam, 1977, pp. 281-298.

  • Y.F. Chen, Y.T Lin and S.C. Wu, Effectiveness of coenzyme Qjo on myocardial preservation during hypothermic cardio­plegie arresi, J. Thorac. Cardiovasc. Surg. 107(1) (1994), 242-247.

  • Yamamura and K. Folkers, eds, Voi. 2, Elsevier, Amsterdam, 1980, pp. 273-288.

Related Projects